EP Patent

EP1863500A2 — Hepatitis c therapies

Assigned to Biocryst Pharmaceuticals Inc · Expires 2007-12-12 · 18y expired

What this patent protects

The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.

USPTO Abstract

The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP1863500A2
Jurisdiction
EP
Classification
—
Expires
2007-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Biocryst Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.